CDx Diagnostics®
Karen Hoffman is a seasoned professional in the field of pathology and clinical research with extensive experience spanning several decades. Currently serving as the Director of Research at CDx Diagnostics® since February 2020, Karen previously held the position of Director of Clinical Trials at Eastchester Center for Cancer Care from 2003 to February 2020. Earlier in the career, Karen worked as the Assistant Laboratory Director at Dianon Systems from 1994 to 2003. Karen's educational background includes a Fellowship in Gynecologic Pathology and a Residency in Anatomic and Clinical Pathology at The Mount Sinai Hospital, along with an M.D. from The George Washington University School of Medicine and Health Sciences, and a Bachelor of Arts in Comparative Literature from Brown University.
This person is not in any teams
CDx Diagnostics®
The mission of CDx Diagnostics® is to provide clinicians with easily implemented, cost-effective tools to preempt cancer through enhanced detection of precancerous cellular changes. This is accomplished by a proprietary diagnostic platform that synthesizes computer imaging, artificial intelligence, molecular biology and three-dimensional cytopathology to detect precancerous change earlier and more reliably than prior methods.